Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study — Stella

Recruiting

Back to Cytomegalovirus Infections trials

Trial locations(1 site)

United States

UMass Chan Medical School, Worcester, Massachusetts

Key details

Sponsor

University of Massachusetts, Worcester

Collaborators

ModernaTX, Inc.

Enrollment target

~100 participants

Started

August 2023

Primary completion

January 2027

Age range

1 Day – 36 Months

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov